Skip to main content
Erschienen in: Heart and Vessels 6/2013

01.11.2013 | Original Article

Acute hyperglycemia reduces myocardial blood flow reserve and the magnitude of reduction is associated with insulin resistance: a study in nondiabetic humans using contrast echocardiography

verfasst von: Sahar S. Abdelmoneim, Mary E. Hagen, Edward Mendrick, Vishwanath Pattan, Benjamin Wong, Barbara Norby, Tamara Roberson, Troy Szydel, Rita Basu, Ananda Basu, Sharon L. Mulvagh

Erschienen in: Heart and Vessels | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

The effect of acute hyperglycemia per se on coronary perfusion in humans is undefined. We evaluated the effects of short-term hyperglycemia on myocardial blood flow reserve (MBFR) in healthy nondiabetic volunteers. Twenty-one nondiabetic volunteers (76 % females, mean ± SD, age 48 ± 5 years) had noninvasive MBFR assessment while exposed to pancreatic clamp with somatostatin and replacement glucagon and growth hormone infusions, with frequent interval plasma glucose (PG) monitoring. Insulin was infused at 0.75 mU/kg/min to mimic postprandial plasma insulin concentrations, and glucose was infused to maintain euglycemia (PG 93.9 ± 7.3 mg/dl) followed by hyperglycemia (PG 231.5 ± 18.1 mg/dl). Myocardial contrast echocardiography (MCE) was performed during each glycemic steady state using continuous infusion of Definity at rest and during regadenoson (Lexiscan 5 ml (400 μg) intravenous bolus) infusion to quantify myocardial blood flow (MBF) and determine MBFR. Insulin resistance (IR) was assessed by glucose infusion rate (GIR; mg/kg/min) at euglycemia. Median stress MBF, MBFR, and β reserve were significantly reduced during acute hyperglycemia versus euglycemia (stress MBF 3.9 vs 5.4, P = 0.02; MBFR 2.0 vs 2.7, P < 0.0001; β reserve 1.45 vs 2.4, P = 0.007). Using a median threshold GIR of 5 mg/kg/min, there was a correlation between GIR and hyperglycemic MBFR (r = 0.506, P = 0.019). MBFR, as determined noninvasively by MCE, is significantly decreased during acute hyperglycemia in nondiabetic volunteers, and the magnitude of this reduction is modulated by IR.
Literatur
1.
Zurück zum Zitat Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM (2005) Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111:3078–3086PubMedCrossRef Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM (2005) Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111:3078–3086PubMedCrossRef
2.
Zurück zum Zitat Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA (1998) Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97:1695–1701PubMedCrossRef Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA (1998) Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97:1695–1701PubMedCrossRef
3.
Zurück zum Zitat Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88:2510–2516PubMedCrossRef Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88:2510–2516PubMedCrossRef
4.
Zurück zum Zitat Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D’Onofrio F (1997) Vascular effects of acute hyperglycemia in humans are reversed by l-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95:1783–1790PubMedCrossRef Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D’Onofrio F (1997) Vascular effects of acute hyperglycemia in humans are reversed by l-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95:1783–1790PubMedCrossRef
5.
Zurück zum Zitat Wei K, Crouse L, Weiss J, Villanueva F, Schiller NB, Naqvi TZ, Siegel R, Monaghan M, Goldman J, Aggarwal P, Feigenbaum H, DeMaria A (2003) Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99m sestamibi single-photon emission computed tomography for detection of coronary artery disease (pb127 multicenter phase 2 trial results). Am J Cardiol 91:1293–1298PubMedCrossRef Wei K, Crouse L, Weiss J, Villanueva F, Schiller NB, Naqvi TZ, Siegel R, Monaghan M, Goldman J, Aggarwal P, Feigenbaum H, DeMaria A (2003) Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99m sestamibi single-photon emission computed tomography for detection of coronary artery disease (pb127 multicenter phase 2 trial results). Am J Cardiol 91:1293–1298PubMedCrossRef
6.
Zurück zum Zitat Cosyns B, Droogmans S, Hernot S, Degaillier C, Garbar C, Weytjens C, Roosens B, Schoors D, Lahoutte T, Franken PR, Van Camp G (2008) Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats. Cardiovasc Diabetol 7:26PubMedCrossRef Cosyns B, Droogmans S, Hernot S, Degaillier C, Garbar C, Weytjens C, Roosens B, Schoors D, Lahoutte T, Franken PR, Van Camp G (2008) Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats. Cardiovasc Diabetol 7:26PubMedCrossRef
7.
Zurück zum Zitat Hansen A, Johansson BL, Wahren J, von Bibra H (2002) C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 51:3077–3082PubMedCrossRef Hansen A, Johansson BL, Wahren J, von Bibra H (2002) C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 51:3077–3082PubMedCrossRef
8.
Zurück zum Zitat Moir S, Hanekom L, Fang ZY, Haluska B, Wong C, Burgess M, Marwick TH (2006) Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging. Heart 92:1414–1419PubMedCrossRef Moir S, Hanekom L, Fang ZY, Haluska B, Wong C, Burgess M, Marwick TH (2006) Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging. Heart 92:1414–1419PubMedCrossRef
9.
Zurück zum Zitat Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA (2001) Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 50:1351–1362PubMedCrossRef Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA (2001) Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 50:1351–1362PubMedCrossRef
10.
Zurück zum Zitat Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S (1998) Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97:473–483PubMedCrossRef Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S (1998) Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97:473–483PubMedCrossRef
11.
Zurück zum Zitat Abdelmoneim SS, Basu A, Bernier M, Dhoble A, Abdel-Kader SS, Pellikka PA, Mulvagh SL (2011) Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: prospective comparison with single-photon emission computed tomography. Diab Vasc Dis Res 8:254–261PubMedCrossRef Abdelmoneim SS, Basu A, Bernier M, Dhoble A, Abdel-Kader SS, Pellikka PA, Mulvagh SL (2011) Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: prospective comparison with single-photon emission computed tomography. Diab Vasc Dis Res 8:254–261PubMedCrossRef
12.
Zurück zum Zitat Porter TR, Adolphson M, High RR, Smith LM, Olson J, Erdkamp M, Xie F, O’Leary E, Wong BF, Eifert-Rain S, Hagen ME, Abdelmoneim SS, Mulvagh SL (2011) Rapid detection of coronary artery stenoses with real-time perfusion echocardiography during regadenoson stress. Circ Cardiovasc Imaging 4:628–635PubMedCrossRef Porter TR, Adolphson M, High RR, Smith LM, Olson J, Erdkamp M, Xie F, O’Leary E, Wong BF, Eifert-Rain S, Hagen ME, Abdelmoneim SS, Mulvagh SL (2011) Rapid detection of coronary artery stenoses with real-time perfusion echocardiography during regadenoson stress. Circ Cardiovasc Imaging 4:628–635PubMedCrossRef
13.
Zurück zum Zitat Abdelmoneim SS, Bernier M, Scott CG, Dhoble A, Ness SA, Hagen ME, Moir S, McCully RB, Pellikka PA, Mulvagh SL (2009) Safety of contrast agent use during stress echocardiography: a 4-year experience from a single-center cohort study of 26,774 patients. JACC Cardiovasc Imaging 2:1048–1056PubMedCrossRef Abdelmoneim SS, Bernier M, Scott CG, Dhoble A, Ness SA, Hagen ME, Moir S, McCully RB, Pellikka PA, Mulvagh SL (2009) Safety of contrast agent use during stress echocardiography: a 4-year experience from a single-center cohort study of 26,774 patients. JACC Cardiovasc Imaging 2:1048–1056PubMedCrossRef
14.
Zurück zum Zitat Vogel R, Indermuhle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C (2005) The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol 45:754–762PubMedCrossRef Vogel R, Indermuhle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C (2005) The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol 45:754–762PubMedCrossRef
15.
Zurück zum Zitat Vogel R, Indermuhle A, Seiler C (2007) Determination of the absolute perfusion threshold preventing myocardial ischaemia in humans. Heart 93:115–116PubMedCrossRef Vogel R, Indermuhle A, Seiler C (2007) Determination of the absolute perfusion threshold preventing myocardial ischaemia in humans. Heart 93:115–116PubMedCrossRef
16.
Zurück zum Zitat Cerqueira MD (2006) Advances in pharmacologic agents in imaging: new a2a receptor agonists. Curr Cardiol Rep 8:119–122PubMedCrossRef Cerqueira MD (2006) Advances in pharmacologic agents in imaging: new a2a receptor agonists. Curr Cardiol Rep 8:119–122PubMedCrossRef
17.
Zurück zum Zitat Kanatsuka H, Lamping KG, Eastham CL, Marcus ML (1990) Heterogeneous changes in epimyocardial microvascular size during graded coronary stenosis. Evidence of the microvascular site for autoregulation. Circ Res 66:389–396PubMedCrossRef Kanatsuka H, Lamping KG, Eastham CL, Marcus ML (1990) Heterogeneous changes in epimyocardial microvascular size during graded coronary stenosis. Evidence of the microvascular site for autoregulation. Circ Res 66:389–396PubMedCrossRef
18.
Zurück zum Zitat Hage FG, Perry G, Heo J, Iskandrian AE (2010) Blunting of the heart rate response to adenosine and regadenoson in relation to hyperglycemia and the metabolic syndrome. Am J Cardiol 105:839–843PubMedCrossRef Hage FG, Perry G, Heo J, Iskandrian AE (2010) Blunting of the heart rate response to adenosine and regadenoson in relation to hyperglycemia and the metabolic syndrome. Am J Cardiol 105:839–843PubMedCrossRef
19.
Zurück zum Zitat Kaul S (2001) The role of capillaries in determining coronary blood flow reserve: implications for stress-induced reversible perfusion defects. J Nucl Cardiol 8:694–700PubMedCrossRef Kaul S (2001) The role of capillaries in determining coronary blood flow reserve: implications for stress-induced reversible perfusion defects. J Nucl Cardiol 8:694–700PubMedCrossRef
20.
Zurück zum Zitat Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD (1995) Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 91:635–640PubMedCrossRef Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD (1995) Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 91:635–640PubMedCrossRef
21.
Zurück zum Zitat Schindler TH, Zhang XL, Vincenti G, Mhiri L, Lerch R, Schelbert HR (2007) Role of PET in the evaluation and understanding of coronary physiology. J Nucl Cardiol 14:589–603PubMedCrossRef Schindler TH, Zhang XL, Vincenti G, Mhiri L, Lerch R, Schelbert HR (2007) Role of PET in the evaluation and understanding of coronary physiology. J Nucl Cardiol 14:589–603PubMedCrossRef
23.
Zurück zum Zitat Fujimoto K, Hozumi T, Watanabe H, Tokai K, Shimada K, Yoshiyama M, Homma S, Yoshikawa J (2006) Acute hyperglycemia induced by oral glucose loading suppresses coronary microcirculation on transthoracic Doppler echocardiography in healthy young adults. Echocardiography 23:829–834PubMedCrossRef Fujimoto K, Hozumi T, Watanabe H, Tokai K, Shimada K, Yoshiyama M, Homma S, Yoshikawa J (2006) Acute hyperglycemia induced by oral glucose loading suppresses coronary microcirculation on transthoracic Doppler echocardiography in healthy young adults. Echocardiography 23:829–834PubMedCrossRef
24.
Zurück zum Zitat Ceriello A, Quagliaro L, D’Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D (2002) Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51:1076–1082PubMedCrossRef Ceriello A, Quagliaro L, D’Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D (2002) Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51:1076–1082PubMedCrossRef
25.
Zurück zum Zitat Fujii N, Tsuchihashi K, Sasao H, Eguchi M, Miurakami H, Hase M, Higashiura K, Yuda S, Hashimoto A, Miura T, Ura N, Shimamoto K (2008) Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients. Heart Vessels 23:9–15PubMedCrossRef Fujii N, Tsuchihashi K, Sasao H, Eguchi M, Miurakami H, Hase M, Higashiura K, Yuda S, Hashimoto A, Miura T, Ura N, Shimamoto K (2008) Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients. Heart Vessels 23:9–15PubMedCrossRef
26.
Zurück zum Zitat Oyama N, Urasawa K, Sakai H, Fujii S, Kitabatake A (2005) Insulin resistance relates to acetylcholine-induced microvascular vasoconstriction in a patient with vasospastic angina: potential implication of causalities between hyperinsulinemia and coronary microcirculation failure. Heart Vessels 20:72–76PubMedCrossRef Oyama N, Urasawa K, Sakai H, Fujii S, Kitabatake A (2005) Insulin resistance relates to acetylcholine-induced microvascular vasoconstriction in a patient with vasospastic angina: potential implication of causalities between hyperinsulinemia and coronary microcirculation failure. Heart Vessels 20:72–76PubMedCrossRef
27.
Zurück zum Zitat DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed
28.
Zurück zum Zitat Harano Y, Hidaka H, Takatsuki K, Ohgaku S, Haneda M, Motoi S, Kawagoe K, Shigeta Y, Abe H (1978) Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism 27:1449–1452PubMedCrossRef Harano Y, Hidaka H, Takatsuki K, Ohgaku S, Haneda M, Motoi S, Kawagoe K, Shigeta Y, Abe H (1978) Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism 27:1449–1452PubMedCrossRef
29.
Zurück zum Zitat Cheung JY, Conover C, Regen DM, Whitfield CF, Morgan HE (1978) Effect of insulin on kinetics of sugar transport in heart muscle. Am J Physiol 234:E70–E78PubMed Cheung JY, Conover C, Regen DM, Whitfield CF, Morgan HE (1978) Effect of insulin on kinetics of sugar transport in heart muscle. Am J Physiol 234:E70–E78PubMed
30.
Zurück zum Zitat Laight DW, Carrier MJ, Anggard EE (2000) Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 47:457–464PubMedCrossRef Laight DW, Carrier MJ, Anggard EE (2000) Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 47:457–464PubMedCrossRef
31.
Zurück zum Zitat Neri S, Calvagno S, Mauceri B, Misseri M, Tsami A, Vecchio C, Mastrosimone G, Di Pino A, Maiorca D, Judica A, Romano G, Rizzotto A, Signorelli SS (2010) Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in subjects with impaired glucose tolerance and type 2 diabetes. Eur J Nutr 49:409–416PubMedCrossRef Neri S, Calvagno S, Mauceri B, Misseri M, Tsami A, Vecchio C, Mastrosimone G, Di Pino A, Maiorca D, Judica A, Romano G, Rizzotto A, Signorelli SS (2010) Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in subjects with impaired glucose tolerance and type 2 diabetes. Eur J Nutr 49:409–416PubMedCrossRef
32.
Zurück zum Zitat Digerness SB, Harris KD, Kirklin JW, Urthaler F, Viera L, Beckman JS, Darley-Usmar V (1999) Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. Free Radic Biol Med 27:1386–1392PubMedCrossRef Digerness SB, Harris KD, Kirklin JW, Urthaler F, Viera L, Beckman JS, Darley-Usmar V (1999) Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. Free Radic Biol Med 27:1386–1392PubMedCrossRef
33.
Zurück zum Zitat Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939–1945PubMedCrossRef Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939–1945PubMedCrossRef
34.
Zurück zum Zitat Fredholm BB, IJ AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527–552PubMed Fredholm BB, IJ AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527–552PubMed
35.
Zurück zum Zitat Topfer M, Burbiel CE, Muller CE, Knittel J, Verspohl EJ (2008) Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake. Cell Biochem Funct 26:833–843PubMedCrossRef Topfer M, Burbiel CE, Muller CE, Knittel J, Verspohl EJ (2008) Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake. Cell Biochem Funct 26:833–843PubMedCrossRef
36.
Zurück zum Zitat Maeda T, Koos BJ (2009) Adenosine A1 and A2A receptors modulate insulinemia, glycemia, and lactatemia in fetal sheep. Am J Physiol Regul Integr Comp Physiol 296:R693–R701PubMedCrossRef Maeda T, Koos BJ (2009) Adenosine A1 and A2A receptors modulate insulinemia, glycemia, and lactatemia in fetal sheep. Am J Physiol Regul Integr Comp Physiol 296:R693–R701PubMedCrossRef
37.
Zurück zum Zitat Palani G, Ananthasubramaniam K (2012) Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications. Cardiol Rev [Epub ahead of print] Palani G, Ananthasubramaniam K (2012) Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications. Cardiol Rev [Epub ahead of print]
38.
Zurück zum Zitat Gordi T, Frohna P, Sun HL, Wolff A, Belardinelli L, Lieu H (2006) A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers. Clin Pharmacokinet 45:1201–1212PubMedCrossRef Gordi T, Frohna P, Sun HL, Wolff A, Belardinelli L, Lieu H (2006) A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers. Clin Pharmacokinet 45:1201–1212PubMedCrossRef
39.
Zurück zum Zitat Lafitte S, Masugata H, Peters B, Togni M, Strachan M, Yao B, Kwan OL, DeMaria AN (2001) Accuracy and reproducibility of coronary flow rate assessment by real-time contrast echocardiography: in vitro and in vivo studies. J Am Soc Echocardiog 14:1010–1019CrossRef Lafitte S, Masugata H, Peters B, Togni M, Strachan M, Yao B, Kwan OL, DeMaria AN (2001) Accuracy and reproducibility of coronary flow rate assessment by real-time contrast echocardiography: in vitro and in vivo studies. J Am Soc Echocardiog 14:1010–1019CrossRef
40.
Zurück zum Zitat Abdelmoneim SS, Dhoble A, Bernier M, Erwin PJ, Korosoglou G, Senior R, Moir S, Kowatsch I, Xian-Hong S, Muro T, Dawson D, Vogel R, Wei K, West CP, Montori VM, Pellikka PA, Abdel-Kader SS, Mulvagh SL (2009) Quantitative myocardial contrast echocardiography during pharmacological stress for diagnosis of coronary artery disease: a systematic review and meta-analysis of diagnostic accuracy studies. Eur J Echocardiogr 10:813–825PubMedCrossRef Abdelmoneim SS, Dhoble A, Bernier M, Erwin PJ, Korosoglou G, Senior R, Moir S, Kowatsch I, Xian-Hong S, Muro T, Dawson D, Vogel R, Wei K, West CP, Montori VM, Pellikka PA, Abdel-Kader SS, Mulvagh SL (2009) Quantitative myocardial contrast echocardiography during pharmacological stress for diagnosis of coronary artery disease: a systematic review and meta-analysis of diagnostic accuracy studies. Eur J Echocardiogr 10:813–825PubMedCrossRef
41.
Zurück zum Zitat Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773–778PubMedCrossRef Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773–778PubMedCrossRef
42.
Zurück zum Zitat Mineoka Y, Fukui M, Tanaka M, Tomiyasu K, Akabame S, Nakano K, Yamazaki M, Hasegawa G, Oda Y, Nakamura N (2012) Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus. Heart Vessels 27(2):160–165PubMedCrossRef Mineoka Y, Fukui M, Tanaka M, Tomiyasu K, Akabame S, Nakano K, Yamazaki M, Hasegawa G, Oda Y, Nakamura N (2012) Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus. Heart Vessels 27(2):160–165PubMedCrossRef
Metadaten
Titel
Acute hyperglycemia reduces myocardial blood flow reserve and the magnitude of reduction is associated with insulin resistance: a study in nondiabetic humans using contrast echocardiography
verfasst von
Sahar S. Abdelmoneim
Mary E. Hagen
Edward Mendrick
Vishwanath Pattan
Benjamin Wong
Barbara Norby
Tamara Roberson
Troy Szydel
Rita Basu
Ananda Basu
Sharon L. Mulvagh
Publikationsdatum
01.11.2013
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 6/2013
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-012-0305-y

Weitere Artikel der Ausgabe 6/2013

Heart and Vessels 6/2013 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.